Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Background: In approximately 10% of asthma patients, symptoms remain uncontrolled despite maximal treatment, representing an unmet clinical need. The causal variants, genes and pathways underlying genetic risk factors have not been fully elucidated, and it is unclear whether there are unique genetic risk factors for this asthma subtype. Methods: We used electronic healthcare records (EHR) linked to UK Biobank to identify asthma patients with high treatment burden and/or worse outcomes. We performed a genome-wide association study (GWAS) with this case population and healthy controls. We sought replication for associated (p≤5×10 −6 ) signals in four independent studies (12 152 cases and 32 316 controls). Replicated signals were fine-mapped and linked to genes and pathways. Results: In total, 7681 participants met our case definition and showed enrichment for adult-onset asthma, female gender and higher BMI compared to asthma individuals not meeting case criteria. GWAS with 7681 cases and 38 405 controls revealed 21 reproducible association signals that had previously been associated with asthma but had a larger effect size in our study. Variant-to-gene mapping highlighted 85 candidate genes, five of which were considered high confidence ( BACH2 , D2HGDH , IL1RL1 , RPS26 , SMAD3 ). Conclusion: We present the first use of EHR in UK Biobank to identify a subtype of asthma enriched for patients with high treatment burden and/or worse outcomes. Our findings support the role of known asthma genes, highlighting genetic risk variants with stronger effect in these groups of patients. The prioritised genes provide potential therapeutic opportunities for this difficult-to-treat patient population.
Funding Information
  • Innovative Medicines Initiative (EU-IMI 115010)
  • NIH Office of the Director (5U19AI070235)
  • NIH Office of the Director (UG3OD035509)
  • NIH Office of the Director (UG3OD035518)
  • NIH Office of the Director (UH3OD023282)
  • Wellcome Trust (218505/Z/19/Z)
  • Wellcome Trust (225221/Z/22/Z)
  • NIH (5UH3OD023282)
  • NIH (R01MH129337)
  • NIH (U19 AI162310)
  • NIH (U24AI179612)
  • NIH (UG3/UH3 OD023282)
  • NIH (UH3OD023282)
  • NIH (UM1 AI160040)
  • National Institute of Allergy and Infectious Diseases (U19 AI 095227)
  • National Institute of Allergy and Infectious Diseases (U19 AI104317)
  • National Institute of Allergy and Infectious Diseases (U19 AI162310)
  • National Institute of Allergy and Infectious Diseases (U24AI179612)
  • National Institute of Allergy and Infectious Diseases (UL1 TR002243)
  • National Institute of Allergy and Infectious Diseases (UM1 AI114271)
  • National Institute of Allergy and Infectious Diseases (UM1 AI160040)
  • Asthma and Lung UK (AUK-CDA-2019-414)
  • Asthma and Lung UK (AUK-PG-2013-188)
  • National Institute of Mental Health (R01MH129337)

This publication has 49 references indexed in Scilit: